Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,199 | 31,874 | 39,979 | 41,690 | 49,751 |
| TOTAL | $27,893 | $33,648 | $42,469 | $45,054 | $52,131 |
| Non-Current Assets | |||||
| PPE Net | 126 | 131 | 137 | 142 | 148 |
| Other Non-Current Assets | 6,687 | 6,697 | 4,423 | 162 | 172 |
| TOTAL | $6,813 | $6,828 | $4,560 | $304 | $319 |
| Total Assets | $34,706 | $40,476 | $47,029 | $45,359 | $52,451 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,181 | 4,497 | 2,859 | 1,685 | 1,301 |
| Accrued Expenses | 2,104 | 1,482 | 2,847 | 2,841 | 4,480 |
| TOTAL | $13,330 | $11,532 | $18,265 | $17,087 | $18,340 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,889 | 12,944 | 6,352 | 9,205 | 12,032 |
| TOTAL | $11,923 | $12,985 | $6,401 | $9,267 | $12,110 |
| Total Liabilities | $25,252 | $24,516 | $24,666 | $26,354 | $30,450 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,980 | 46,633 | 45,710 | 45,396 | 37,409 |
| Common Shares | 16 | 15 | 15 | 13 | 12 |
| Retained earnings | -209,044 | -200,034 | -190,600 | -182,111 | -174,159 |
| TOTAL | $9,454 | $15,960 | $22,362 | $19,005 | $22,001 |
| Total Liabilities And Equity | $34,706 | $40,476 | $47,029 | $45,359 | $52,451 |